Cyclooxygenase-2 (COX-2) expression is increased in the majority of colorectal tumours [2] and this induction is associated with advanced tumour stage and correlates with poor clinical outcomes [3]. This evidence concerns the gene PTGS2 and colorectal neoplasm.